Literature DB >> 28458139

Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo.

Yuan Yan1, Na Liu2, Ni Hou2, Lei Dong3, Jie Li4.   

Abstract

Curative treatment of patients with hepatocellular carcinoma (HCC) is poor. There is an urgent need to develop more effective strategies for the chemoprevention of HCC. Chlorogenic acid (CGA), a type of polyphenol present in the diet, especially from coffee, has many biological activities. Patients with viral hepatitis who drank coffee everyday experienced a reduction in the incidence of HCC. In the present study, we evaluated the effects of CGA on HCC. CGA inhibited the proliferation of HepG2 cells in vitro and the progression of HepG2 xenograft in vivo. CGA induced the inactivation of ERK1/2 and suppressed the expression of MMP-2 and MMP-9 in HepG2 xenograft tissue. These data demonstrate that CGA can prevent the progression of HCC through multiple pathways. CGA appears to be an effective chemopreventive agent for hepatocellular carcinoma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoprevention; Chlorogenic acid; Chlorogenic acid (PubChem CID: 1794427); ERK; Hepatocellular carcinoma; MMP

Mesh:

Substances:

Year:  2017        PMID: 28458139     DOI: 10.1016/j.jnutbio.2017.04.007

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  20 in total

1.  Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis.

Authors:  Yanfei Jiang; Hao Nan; Na Shi; Wenfang Hao; Juane Dong; Hongying Chen
Journal:  Mol Biol Rep       Date:  2021-03-18       Impact factor: 2.316

2.  Computational identification of bioactive compounds from Cydonia oblonga Mill. against hepatocellular carcinoma by targeting pTEN and HBx-interacting protein.

Authors:  Elhan Khan; Iffat Zareen Ahmad
Journal:  J Mol Model       Date:  2022-06-17       Impact factor: 1.810

3.  Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression.

Authors:  Yao Liu; Ying Feng; Yuxin Li; Ying Hu; Qun Zhang; Yunyi Huang; Ke Shi; Chongping Ran; Jie Hou; Guiqin Zhou; Xianbo Wang
Journal:  Front Pharmacol       Date:  2020-06-10       Impact factor: 5.810

4.  Interpreting the Molecular Mechanisms of Yinchenhao Decoction on Hepatocellular Carcinoma through Absorbed Components Based on Network Pharmacology.

Authors:  Jijia Sun; Tao Han; Tao Yang; Yunhui Chen; Jihan Huang
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

Review 5.  The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases.

Authors:  Sha Li; Hor Yue Tan; Ning Wang; Fan Cheung; Ming Hong; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2018-02-04       Impact factor: 6.543

6.  Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.

Authors:  Maria Grazia Refolo; Catia Lippolis; Nicola Carella; Aldo Cavallini; Caterina Messa; Rosalba D'Alessandro
Journal:  Int J Mol Sci       Date:  2018-05-19       Impact factor: 5.923

7.  Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.

Authors:  Carla Holandino; Michelle Nonato de Oliveira Melo; Adriana Passos Oliveira; João Vitor da Costa Batista; Marcia Alves Marques Capella; Rafael Garrett; Mirio Grazi; Hartmut Ramm; Claudia Dalla Torre; Gerhard Schaller; Konrad Urech; Ulrike Weissenstein; Stephan Baumgartner
Journal:  BMC Complement Med Ther       Date:  2020-07-09

8.  Anti-inflammatory Effect of Astragalin and Chlorogenic Acid on Escherichia coli-Induced Inflammation of Sheep Endometrial Epithelium Cells.

Authors:  Xuequan Hu; Meng Wang; Yangyang Pan; Yingying Xie; Jinhui Han; Xingyun Zhang; Robert Niayale; Honghong He; Qin Li; Tian Zhao; Yan Cui; Sijiu Yu
Journal:  Front Vet Sci       Date:  2020-04-30

9.  Coffee consumption by type and risk of digestive cancer: a large prospective cohort study.

Authors:  Kim Tu Tran; Helen G Coleman; Úna C McMenamin; Chris R Cardwell
Journal:  Br J Cancer       Date:  2019-05-01       Impact factor: 7.640

10.  Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity.

Authors:  Jun Ye; Yue Gao; Ming Ji; Yanfang Yang; Zhaohui Wang; Baolian Wang; Jing Jin; Ling Li; Hongliang Wang; Xiaoyan Xu; Hengfeng Liao; Chunfang Lian; Yaqi Xu; Renjie Li; Tong Sun; Lili Gao; Yan Li; Xiaoguang Chen; Yuling Liu
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.